November 16, 2018, Friday
Shares of Dr.Redyy's closed at Rs 2,470.85 a unit, up by 0.36 per cent compared to the previous close, at BSE on Friday
November 16, 2018, Friday
HealthifyMe is a personal health training and nutrition app
November 16, 2018, Friday
The stock hit a new high of Rs 1,574, up 3% on the BSE today.
November 16, 2018, Friday
The approved product is generic version of Sanofi-Aventis US' Aubagio
November 16, 2018, Friday
Nifty outlook and top trading ideas by Jay Anand Thakkar ,CMT -Assistant Vice President - Equity Research, Anand Rathi Research
November 15, 2018, Thursday
Mount Elizabeth, Gleneagles, Parkway and Pantai are some of the well-known IHH brands in Asia
November 14, 2018, Wednesday
Analysts cut earnings estimates on muted India business growth outlook, rising expenses on specialty launches in the US
November 14, 2018, Wednesday
Targets Rs 100 billion revenue in the next five years
November 14, 2018, Wednesday
The company's board approved a scheme of arrangement between Apollo Hospitals Enterprise and Apollo Pharmacies Ltd
November 14, 2018, Wednesday
Revenue from operations of the company stood at Rs 5.19 billion in the quarter
November 14, 2018, Wednesday
The stock was down 5 per cent at Rs 533, trading at its lowest level since July 17, 2018, on BSE.
November 14, 2018, Wednesday
The board also approved the allotment of Rs 230 million equity shares through preferential issue to Northern TK Ventures
November 13, 2018, Tuesday
Domestic growth is likely to remain firm going ahead, while US growth led by new launches and speciality products should drive earnings
November 13, 2018, Tuesday
Company misses revenue estimates too, delivering a top line of Rs 69.37 bn, up a moderate 4.3%. Analysts had expected double-digit revenue ...
November 13, 2018, Tuesday
The senior management of Aurobindo said they are looking at launching the Oncology products in the US market by the end of this year
November 13, 2018, Tuesday
The board of Fortis has also approved the appointment of four IHH nominees on the company's board
November 13, 2018, Tuesday
Acquisition to help the company build a specialty pipeline in the US
November 13, 2018, Tuesday
The company reported a 21.7 per cent decline in net profit at Rs 6.11 billion for the quarter ended September 2018, owing to rise in costs.
November 13, 2018, Tuesday
Here's a look at the top stocks that may remain in focus in today's trade -
November 12, 2018, Monday
The company was able to improve its US formulations revenues by 6.1 per cent year-on-year at Rs 22.27 billion.
November 12, 2018, Monday
The Fortis stock has seen an erosion of 5.4% since the deal was announced in mid-July
November 09, 2018, Friday
The company has proposed to buy a minimum number of 1.25 million shares from the open market route in the six-month period
November 08, 2018, Thursday
Sources indicated the resignation comes in at a time when the management control of the firm is changing and the new promoters are unlikely to ...
November 08, 2018, Thursday
Domestic market has contributed a third of Natco Pharma's revenues of Rs 22 billion in 2017-18, though slipped in sales for the first time
November 08, 2018, Thursday
Singh has steered the organisation over the past three and a half years
November 08, 2018, Thursday
It is the first quarter of sustainable product sales growth since 2014 and shares in the group, which staved off a takeover bid from Pfizer four ...
November 07, 2018, Wednesday
Insulin Glargine is the first biosimilar from India to be approved and launched in Japan
November 06, 2018, Tuesday
Operating margin declined to 28.5 per cent as against 29 per cent a year ago
November 06, 2018, Tuesday
At NSE, shares of the company dropped 5.87% to close at Rs 529.95
November 06, 2018, Tuesday
The stock was down 5% at Rs 534, trading at its lowest level since June 6, 2018 on the BSE.
November 06, 2018, Tuesday
Vinay Kumar, a chronic diabetic living on the insulin pump, is helping early detection and complete management of diabetes through his novel ...
November 06, 2018, Tuesday
Tender business, which accounts for around 20% of consolidated sales, came under pressure because of intense competition and aggressive pricing
November 05, 2018, Monday
Company cautious on prospects, given supply disruptions & commodity inflation, among others
November 05, 2018, Monday
The company noted in a statement that the net profit for Q2FY19 was primarily impacted by impairment of goodwill and investments
November 05, 2018, Monday
The latest Form 483 with 8 observations came as a clear setback for the company, which was hoping to complete the remediation without giving a ...
November 05, 2018, Monday
The stock has dipped 8% to Rs 558 on the BSE after the pharmaceutical company posted 11% decline in its consolidated net profit at Rs 3.77 ...
November 05, 2018, Monday
Company had a loan book of Rs 527.93 bn in Q2FY19
November 03, 2018, Saturday
During the quarter, the research and development spend came in at Rs 1.3 billion, as against Rs 1 billion in Q2FY18
November 03, 2018, Saturday
Ebitda dipped 20% YoY to Rs 6.87 billion
November 01, 2018, Thursday
The stock dropped 4.13 per cent to end at Rs 852.20 on the BSE. Intra-day, it declined 4.49 per cent to Rs 849
November 01, 2018, Thursday
Glenmark Pharmaceuticals Thursday announced the launch of Nourkrin, used to treat hair loss, in the Russian market. The product catering to ...
